KRMD Stock Analysis: Buy, Sell, or Hold?
KRMD - KORU Medical Systems, Inc. Common Stock (DE)
$4.25
0.03 (0.71%)
▲
5d:
-4.06%
30d:
-10.9%
90d:
-31.78%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 06, 2026
Get Alerted When KRMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: KRMD trading at deep discount. Market pricing in -47.1% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: KRMD trading at deep discount. Market pricing in -47.1% annual earnings decline, creating value opportunity for patient investors.
In-depth Analysis How we analyze
Valuation Analysis: KRMD is currently trading at $4.25, which is considered oversold relative to its 30-day fair value range of $4.29 to $4.77. From a valuation perspective, the stock is trading at a discount (Forward PE: 50.0) compared to its historical average (338.3). Remarkably, the market is currently pricing in an annual earnings decline of 47.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, KRMD is in a downtrend. Immediate support is located at $4.10, while resistance sits at $4.47.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $6.80 (+60.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, KRMD is in a downtrend. Immediate support is located at $4.10, while resistance sits at $4.47.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $6.80 (+60.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$4.29 -
$4.77
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
83.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 60.0% below Wall St target ($6.80)
Fair Price Analysis
30-Day Fair Range
$4.29 -
$4.77
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.41
(9.6%)
Support & Resistance Levels
Support Level
$4.10
Resistance Level
$4.47
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
50.00
Wall Street Target
$6.80
(+60.0%)
Revenue Growth (YoY)
23.3%
Earnings Growth (YoY)
-66.0%
Profit Margin
-6.4%
Valuation Discount vs History
-47.1% cheaper
PE vs Historical
50.0 vs 338.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-47.1%
(market-implied from PE analysis)
1-Year Target
$3.83
(-10%)
2-Year Target
$3.44
(-19%)
3-Year Target
$3.10
(-27%)
3-Yr Target (if PE normalizes)
(PE: 50→338)
$20.96
(+393%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 50.0 to 338.3
Stabilization Target:
$28.76
(+576.6%)
PE Expansion Potential:
+576.6%
Share & Embed Analysis
Last updated: March 31, 2026 2:00 AM ET
Data refreshes hourly during market hours. Next update: 3:00 AM
Data refreshes hourly during market hours. Next update: 3:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KRMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$607 | 55 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$94 | 55 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 57 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$318 | 63 BUY |
|
AVTR
Avantor Inc |
HOLD
21 analysts |
$11 | 61 BUY |
